Sichuan Kelun Pharmaceutical Co., Ltd.

It has a significant therapeutic effect on the dryness symptoms of primary Sjögren's syndrome, and can significantly improve the symptoms of dry mouth, dry eyes, dry nose and dry vaginal mucosa. It can antagonize the inhibition of salivary gland secretion caused by M receptor antagonists such as atropine, correct drug-induced dry mouth caused by taking certain drugs and dry mouth caused by radiotherapy in the oropharyngeal area. This product can enhance the level of glutathione in the liver, significantly enhance the activity of glutamylcysteine synthetase and glutathione reductase, thereby enhancing the vitality of liver cells, increasing bile secretion, and having a choleretic effect.

It can inhibit the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, damaging viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

Contains an essential amino acid to non-essential amino acid ratio (E/N) of 1:2.5, which can promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing.

It can avoid the possible complications of rapid intravenous nutrition in patients with hyponutrition and hypoproteinemia

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

Promote normal protein metabolism in the human body, correct negative nitrogen balance, supplement protein, and accelerate wound healing

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.